EndoChoice Holdings Inc. (GI) Shares Down 5.3%
EndoChoice Holdings Inc. (NYSE:GI) shares were down 5.3% during trading on Friday . The company traded as low as $5.32 and last traded at $5.33, with a volume of 52,582 shares trading hands. The stock had previously closed at $5.63.
A number of research analysts have recently commented on GI shares. Zacks Investment Research raised EndoChoice Holdings from a “hold” rating to a “buy” rating and set a $5.25 target price on the stock in a research note on Tuesday, July 5th. JPMorgan Chase & Co. initiated coverage on EndoChoice Holdings in a report on Wednesday, July 13th. They issued an “overweight” rating for the company.
The stock’s 50 day moving average price is $4.84 and its 200 day moving average price is $4.99. The stock’s market capitalization is $138.64 million.
EndoChoice Holdings (NYSE:GI) last posted its earnings results on Wednesday, May 4th. The company reported ($0.68) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.55) by $0.13. The firm earned $18.46 million during the quarter, compared to analyst estimates of $18.34 million. The business’s revenue was up 10.2% on a year-over-year basis. During the same period in the prior year, the firm earned ($1.00) earnings per share. Equities research analysts expect that EndoChoice Holdings Inc. will post ($2.01) EPS for the current fiscal year.
An institutional investor recently raised its position in EndoChoice Holdings stock. Bank of Montreal Can boosted its stake in shares of EndoChoice Holdings Inc. (NYSE:GI) by 25.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 566,845 shares of the company’s stock after buying an additional 115,260 shares during the period. Bank of Montreal Can owned about 2.29% of EndoChoice Holdings worth $4,733,000 at the end of the most recent quarter.
Endochoice Holdings, Inc, formerly ECPM Holdings, LLC, is a medical device company. The Company is focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers. It offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.